GCM
CVS icon

Genus Capital Management’s CVS Health CVS Stock Holding History

Genus Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-35,665
Closed -$2.56M – 212
2026
Q1 		$2.56M Sell
35,665
-43,500
-55% -$3.35M 0.29% 104
2025
Q4 		$6.28M Buy
79,165
+14,565
+23% +$1.15M 0.73% 49
2025
Q3 		$4.87M Buy
+64,600
New +$4.43M 0.57% 61

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Genus Capital Management's CVS Position: Q2 2026 in Review

Genus Capital Management sold out of CVS Health (CVS) in Q2 2026, closing a stake of 35,665 shares — an estimated $2.56M sold.

Genus Capital Management first reported a position in CVS in Q3 2025 and held it in 3 quarters. The position peaked at $6.28M in Q4 2025. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Genus Capital Management reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Genus Capital Management sold 35,665 CVS Health shares in Q2 2026, an estimated $2.56M.
  • Genus Capital Management first reported a position in CVS Health in Q3 2025 and held it in 3 quarters.
  • Genus Capital Management's CVS Health position peaked at $6.28M in Q4 2025.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.